NCT04936490
Unknown
Phase 1
Efficacy and Safety of Crocin Supplementation in Patients With Central Serous Chorioretinopathy (CSCR)
Overview
- Phase
- Phase 1
- Intervention
- Crocin
- Conditions
- Chorioretinopathy, Central Serous
- Sponsor
- Shiraz University of Medical Sciences
- Enrollment
- 40
- Locations
- 1
- Primary Endpoint
- Best-corrected visual acuity (BCVA)
- Last Updated
- 4 years ago
Overview
Brief Summary
Preclinical and clinical evidence support the protective effect of crocin on different pathologic pathways involved in central serous chorioretinopathy (CSCR). They involve inflammation, oxidative stress, mineralocorticoid pathway, and also stress-related injuries. It also showed that crocin has a protective effect on the retinal pigmented epithelium (RPE) layer. Based on the mentioned evidence the study designed to evaluate the efficacy and safety of 2-month crocin supplementation (15 mg/d) in 40 patients with CSCR in a randomized controlled blinded clinical trial.
Investigators
Mojtaba Heydari
Principal Investigator
Shiraz University of Medical Sciences
Eligibility Criteria
Inclusion Criteria
- •age of 18-60 years old
- •The diagnosis of CSCR based on clinical and imagining evaluation
- •informed consent
Exclusion Criteria
- •Chronic CSCR
- •Laser treatment (6 months prior to enrollment)
- •IVB treatment (3 months prior to enrollment)
- •Other retinal diseases
- •History of eye diseases
- •Diabetes Mellitus
- •Renal or hepatic diseases
- •Allergy to saffron or crocin
- •Pregnancy or lactation
- •Beta-blocker, diuretic, or corticosteroid (1 week prior to enrollment) Bleeding tendency or any coagulation disorder
Arms & Interventions
Crocin
Intervention: Crocin
Placebo
Intervention: Placebo
Outcomes
Primary Outcomes
Best-corrected visual acuity (BCVA)
Time Frame: 8 weeks
Secondary Outcomes
- Total number of reported adverse events(8 weeks)
- Foveal thickness (μm)(8 weeks)
- Subfoveal choroidal thickness (μm)(8 weeks)
- Subretinal fluid height (μm)(8 weeks)
- Number of participants need to laser therapy(8 weeks)
Study Sites (1)
Loading locations...
Similar Trials
Recruiting
Phase 2
Efficacy and Safety of Crocin Supplementation in Patients With Central SerousChorioretinopathy (CSCR)Central serous chorioretinopathy.Central serous chorioretinopathyH35.71IRCT20110811007297N7Shiraz University of Medical Sciences40
Recruiting
Phase 2
Evaluation of the effect of crocin on prevention of atrial fibrillation after heart surgeryIRCT20120520009801N4Mashhad University of Medical Sciences80
Recruiting
Phase 3
Therapeutic effect of crocin along with chemotherapy regimens in breast cancerBreast cancer.Malignant neoplasm of breast of unspecified siteC50.9IRCT20131017015044N3Mashhad University of Medical Sciences100
Recruiting
Phase 3
Evaluation effect of crocin in cardiac complication due to doxorubicin in patients with breast cancerIRCT20131017015044N5Mashhad University of Medical Sciences60
Completed
Phase 3
Effect of Crocin and Metformin in patients with type 2 diabetesIRCT20170611034458N2Esfahan University of Medical Sciences60